Tapentadol is partially metabolized through the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medication that increase or repress the activity/expression of one or more of these enzymes, and with substrates of these enzymes (resulting from Level of competition to the enzyme); some enzyme mediators/substrates deman… Read More